CARRIE WHITEHEAD: Open Payments
NPI 1750833232 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,695 in 55 payments from 17 companies in 2025. Trend: 2023 $422 · 2024 $903 · 2025 $2,695
Food & beverage: $1,421Travel & lodging: $1,188Education: $85
| Company | Payments | Amount |
|---|---|---|
| Vantive US Healthcare LLC | 12 | $1,611 |
| AKEBIA THERAPEUTICS INC | 2 | $152 |
| Mallinckrodt Hospital Products Inc. | 3 | $143 |
| Novartis Pharmaceuticals Corporation | 7 | $137 |
| Novo Nordisk Inc | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| AstraZeneca Pharmaceuticals LP | 5 | $97 |
| OPKO Pharmaceuticals, LLC | 4 | $75 |
| Ardelyx, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
Products named: Renal - Chronic, Vafseo, Renal - Acute, ACTHAR, Fabhalta, JYNARQUE, FARXIGA, RAYALDEE.
Industry payments across GA — which companies pay providers there.
